Tolterodine Extended Release Attenuates Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

Journal of Urology

Volumn 179, Issue 5 SUPPL., 2008, Pages

  Kaplan, Steven A ^a   Walmsley, Konstantin ^a   Te, Alexis E ^b  

^a Columbia University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

prostate; prostatic hyperplasia; tolterodine; urinary tract; urination disorders

Indexed keywords

DOXAZOSIN; TAMSULOSIN; TOLTERODINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MORBIDITY; NOCTURIA; PENIS ERECTION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SCORING SYSTEM; SUSTAINED DRUG RELEASE; TREATMENT DURATION; TREATMENT FAILURE; URINARY FREQUENCY; URINE FLOW RATE; URINE RETENTION; XEROSTOMIA;

EID: 41649112729     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.03.142     Document Type: Article

References (0)